News

X4 Pharmaceuticals Gets Fast Track Regulatory Designation for Neutropenia Drug
The drug Mavorixafor was previously granted the Fast Track designation for the treatment of WHIM syndrome, a rare immunodeficiency indication for which it received FDA approval in April 2024, X4 said.
Indie App Spotlight: ‘Pill Buddy’ is a really fun way to keep track of your medicines
Welcome to Indie App Spotlight. This is a weekly 9to5Mac series where we showcase the latest apps in the indie ...
The Journal Times4d
Union Grove star out for 'even cooler' end to senior year at state track meet
Lamers’ sister, Brooklyn, who graduated from Union Grove in 2024, influenced Ashley with her success. Ashley was inspired to ...
University of California, San Francisco4d
Your Fitness Tracker Could Help Doctors Spot Health Risks Early
Health trackers keep tabs on nearly 1 in 4 Americans at this point. Professor of Medicine Sandeep Kishore, MD, PhD, MSc, ...
TMCnet5d
Tempest Receives Orphan Drug Designation from the European Medicines Agency for Amezalpat for the Treatment of Patients with HCC
The multiple regulatory designations were granted following strong positive results from a global randomized Phase 1b/2 study in first-line HCC demonstrating superior outcomes for amezalpat ...